Table 3.
Year after inebilizumab initiation | Grade, n | |||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
1 | 29 | 14 | 2 | 0 |
2 | 19 | 13 | 3 | 0 |
3 | 19 | 11 | 1 | 0 |
4 | 15 | 9 | 2 | 0 |
⩾ 5 | 8 | 6 | 2 | 1 |
AQP4: aquaporin-4; Ig: immunoglobulin.
Year after inebilizumab initiation | Grade, n | |||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
1 | 29 | 14 | 2 | 0 |
2 | 19 | 13 | 3 | 0 |
3 | 19 | 11 | 1 | 0 |
4 | 15 | 9 | 2 | 0 |
⩾ 5 | 8 | 6 | 2 | 1 |
AQP4: aquaporin-4; Ig: immunoglobulin.